Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer
- 1 January 1990
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Chemotherapy and Pharmacology
- Vol. 25 (6), 435-439
- https://doi.org/10.1007/bf00686055
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?Cancer Chemotherapy and Pharmacology, 1988
- Time dependency of adriamycin and adriamycinol kineticsCancer Chemotherapy and Pharmacology, 1983
- PLASMA PHARMACOKINETICS OF ADRIAMYCIN AND ADRIAMYCINOL - IMPLICATIONS FOR THE DESIGN OF INVITRO EXPERIMENTS AND TREATMENT PROTOCOLS1983
- Appendix B: Computer ProgramsPublished by Springer Science and Business Media LLC ,1980
- Mathematical model for adriamycin (Doxorubicin) pharmacokineticsCancer Chemotherapy and Pharmacology, 1979
- Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological FluidsJournal of Liquid Chromatography, 1978
- Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.1977
- Clinical effects and pharmacokinetics of different dosage schedules of adriamycin.1976
- Preliminary pharmacokinetic model for adriamycin (NSC-123127).1975
- THE PERSISTENCE OF ADRIAMYCIN IN MAN AND RATBritish Journal of Clinical Pharmacology, 1974